Company intelligence / Profile preview

GreenVenus

Davis, California, United States

Ownership: Private
Development stage: Other

Overview

GreenVenus has demonstrated successful gene editing of the PPO gene in avocados (reducing browning), developed non-GMO, browning-resistant avocado lines, and gene-edited grape cultivars with natural antioxidant preservation—enabling premium wines without sulfites. Lettuce cultivars for indoor/vertical farming show doubled growth rate versus conventional varieties. Specialty pea partnership aims to deliver resilient, allergen-free plant proteins

Modalities: Gene editingCRISPR-based therapy (for crops, not humans)Precision geneticsSpeed breedingPlant propagation technology
Industry: Agriculture & AgTech

Partnerships

UC Davis/Ralph M. Parsons Foundation Plant Transformation Facility (collaboration for grape regeneration platform)Plant Research (NZ) Ltd (development of climate-resilient pea varieties)

Beyond the preview

Go deeper on GreenVenus.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on GreenVenus.

Explore the full profile